Call Pharmacy +91 90310 13315
H

Tazloc-CT 6.25 Tablet

Telmisartan (40mg) + Chlorthalidone (6.25mg)

₹131.25


Product Code: 74476
Availability: In Stock
Manufacturer: USV Ltd
Constituents

Telmisartan (40mg) + Chlorthalidone (6.25mg)

Usage of Tazloc-CT 6.25 Tablet

Tazloc-CT 6.25 Tablet is used in the treatment of high blood pressure.

Possible Side-effects

Common
  • Dizziness
  • Altered blood lipids

Unit

1 Strip of 10 Tablet

Manufacturer

USV Ltd

Disclaimer

Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.

How to use Tazloc-CT 6.25 Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Tazloc-CT 6.25 Tablet is to be taken with food.

How Medicine Works

Tazloc-CT 6.25 Tablet is a combination of two medicines: Telmisartan and chlorthalidone, which lowers blood pressure effectively. Telmisartan is an angiotensin receptor blocker (ARB). It works by blocking the hormone angiotensin thereby relaxing blood vessels. This allows the blood to flow more smoothly and the heart to pump more efficiently. Chlorthalidone is a diuretic that removes extra water and certain electrolytes from the body. Over time it also relaxes blood vessels and improves blood flow.

Related Warnings

Taking Chlorthalidone with alcohol may have additive effects in lowering your blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.

Tazloc-CT 6.25 Tablet is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.

Tazloc-CT 6.25 Tablet is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.

Tazloc-CT 6.25 Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.

Tazloc-CT 6.25 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Tazloc-CT 6.25 Tablet may be needed. Please consult your doctor.
Use of Tazloc-CT 6.25 Tablet is not recommended in these patients.

Tazloc-CT 6.25 Tablet should be used with caution in patients with liver disease. Dose adjustment of Tazloc-CT 6.25 Tablet may be needed. Please consult your doctor.
Use of Tazloc-CT 6.25 Tablet is not recommended in patients with severe liver disease.

Expert Advice

Frequently Asked Questions (FAQs)

Similar Products

Featured Products